Floatz logo

Acetylsalicylic Acid

Left Atrial Appendage Closure

Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de QuebecPhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Left Atrial Appendage Closure cohort.

Asset / SponsorPhaseRating
Apixaban
National Medical Research Center for Therapy and Preventive Medicine
Phase 4BB
Plavix
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec
Phase 4BB
Dabigatran
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec
Phase 4BB
Edoxaban
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec
Phase 4BB
Rivaroxaban
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec
Phase 4BB

Same molecule, other indications

Acetylsalicylic Acid is also rated in:

myocardial infarctionDormant
A
Indicative ·
83 / 100
View asset →
coronary artery disorderDormant
BBB
Indicative ·
79 / 100
View asset →
cardiovascular disorderDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →